AI and Pharmacovigilance Under the FDA's New Emerging Drug Safety Technology Program – The Good Bot Podcast

Troutman Pepper
Contact
Join Troutman Pepper Partner Brett Mason for a podcast series analyzing the intersection of artificial intelligence (AI), health care, and the law.

In this installment of The Good Bot, host Brett Mason is joined by Partner Judy O'Grady and Associate Kyle Dolinsky to discuss the FDA’s new Emerging Drug Safety Technology Program (EDSTP) and how this program encourages the use of AI to improve the efficient collection, processing, and evaluation See more +

Join Troutman Pepper Partner Brett Mason for a podcast series analyzing the intersection of artificial intelligence (AI), health care, and the law.

In this installment of The Good Bot, host Brett Mason is joined by Partner Judy O'Grady and Associate Kyle Dolinsky to discuss the FDA’s new Emerging Drug Safety Technology Program (EDSTP) and how this program encourages the use of AI to improve the efficient collection, processing, and evaluation of single and aggregate patient safety data. They further discuss how the use of AI technologies is expected to reduce costs associated with pharmacovigilance in the future. See less -

Embed
Copy

Other MultiMedia by Troutman Pepper

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Troutman Pepper

Written by:

Troutman Pepper
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Troutman Pepper on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide